Please Wait a Moment
X

CTS History

01Aug

Source Plasma Testing

SuperUser Account |01 Aug, 2015 | Return|

In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.

About the Author

Related

Research Consortium

CTS Research Consortium was established to further CTS’s leadership in infectious disease research....

Read More >
Assay Conversion

Assay Conversion

In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...

Read More >

Operational Excellence

CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...

Read More >
On-time test results

On-time test results

Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...

Read More >
Implementation of a COVID-19 Test

Implementation of a COVID-19 Test

CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...

Read More >
Pooled Babesia

Pooled Babesia

Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...

Read More >